ArticleCureus2024
Beyond The Basics: Unveiling Superior Vena Cava Compression in Hodgkin's Lymphoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hodgkin's lymphoma (HL) is a malignancy of the lymphocytes in the lymph nodes and presents with non-specific systemic symptoms like fever, night sweats, and weight loss. While HL often involves the mediastinum, it rarely causes superior vena cava (SVC) syndrome, and eosinophilia is noted in approximately 15% of cases. Here, we report a unique presentation of HL in a 52-year-old male with a history of chronic pruritus, chronic kidney disease, and inactive hepatitis B. The patient presented with progressive cough and dyspnea over an eight-month period and developed right-sided ptosis, neck swelling, and engorged veins in the chest, suggesting Horner's syndrome and SVC syndrome. Imaging revealed an enlarged mediastinal mass and a pleural effusion, with subsequent biopsy confirming classical HL. Notably, the patient exhibited severe eosinophilia and a pruritic rash, which are uncommon features seen with HL. Following a multidisciplinary discussion, he was diagnosed with stage IV B x (bulky) HL and was started on a chemotherapy regimen with brentuximab vedotin plus AVD, which led to significant symptom resolution and reduction in tumor size. This case highlights the importance of considering HL in patients presenting with chronic pruritus, eosinophilia, and mediastinal masses. It emphasizes the need for comprehensive diagnostic evaluation in challenging cases and underscores the effectiveness of modern chemotherapy regimens in managing advanced stages of HL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.